Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and consensus molecular subtypes

Clinical Cancer Research

Volumn 24, Issue 5, 2018, Pages 1062-1072

  Loree, Jonathan M ^a   Pereira, Allan A L ^a   Lam, Michael ^a   Willauer, Alexandra N ^a   Raghav, Kanwal ^a   Dasari, Arvind ^a   Van Morris, K ^a   Advani, Shailesh ^a   Menter, David G ^a   Eng, Cathy ^a   Shaw, Kenna ^a   Broaddus, Russell ^a   Routbort, Mark J ^a   Liu, Yusha ^a   Morris, Jeffrey S ^a   Luthra, Rajyalakshmi ^a   Meric Bernstam, Funda ^a   Overman, Michael J ^a   Maru, Dipen ^a   Kopetz, Scott ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SMAD4 PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BRAF GENE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; COHORT ANALYSIS; COLORECTAL CANCER; CONSENSUS MOLECULAR SUBTYPE; CONTROLLED STUDY; CTNNB1 GENE; FEMALE; GENE; GENE MUTATION; GNAS GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; OVERALL SURVIVAL; PIK3CA GENE; PRIORITY JOURNAL; PTEN GENE; RECTUM; RETROSPECTIVE STUDY; SIGMOID; SMAD4 GENE; TUMOR SUPPRESSOR GENE; BIOPSY; CLASSIFICATION; COLON; COLORECTAL TUMOR; DNA MICROARRAY; GENETICS; HIGH THROUGHPUT SEQUENCING; MICROSATELLITE INSTABILITY; MIDDLE AGED; MORTALITY; MUTATION RATE; PATHOLOGY; PROGNOSIS;

ADULT; BIOMARKERS, TUMOR; BIOPSY; COLON; COLORECTAL NEOPLASMS; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION RATE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RECTUM; RETROSPECTIVE STUDIES;

EID: 85046579237     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-17-2484     Document Type: Article

References (17)

1. Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, et al. Molecular biomarkers for the evaluation of colorectal cancer: guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology. J Clin Oncol 2017;35: 1453–96.
2. Meric-Bernstam F, Brusco L, Shaw K, Horombe C, Kopetz S, Davies MA, et al. Feasibility of large-scale genomic testing to facilitate enrollment onto genomically matched clinical trials. J Clin Oncol 2015;33:2753–62.
3. Chaturvedi A, Green PE, Caroll JD. K-modes clustering. J Classif 2001; 18:35–55.
4. Huang Z. Extensions to the k-means algorithm for clustering large data sets with categorical values. Data Min Knowl Discov 1998;2:283–304.
5. San OM, Huynh V-N, Nakamori Y. An alternative extension of the k-means algorithm for clustering categorical data. Int J Appl Math Comput Sci 2004; 14:241–7.
6. Roever C, Raabe N, Luebke K, Ligges U, Szepannek G, Zentgraf M. klaR: Classification and visualization2014. Available from: https://cran.r-project.org/web/packages/klaR/index.html
7. Wickham H. Elegant Graphics for Data Analysis - ggplot2. New York: Springer-Verlag; 2009. Available from: https://cran.r-project.org/web/packages/ggplot2/citation.html
8. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47.
9. Zhang J, Zheng J, Yang Y, Lu J, Gao J, Lu T, et al. Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases. Sci Rep 2015;5:18678.
10. Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, Nishihara R, et al. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 2012;61:847–54.
11. Takahashi Y, Sugai T, Habano W, Ishida K, Eizuka M, Otsuka K, et al. Molecular differences in the microsatellite stable phenotype between left-sided and right-sided colorectal cancer. Int J Cancer 2016;139:2493–501.
12. Albuquerque C, Baltazar C, Filipe B, Penha F, Pereira T, Smits R, et al. Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability. Genes Chromosomes Cancer 2010;49:746–59.
13. Rosty C, Young JP, Walsh MD, Clendenning M, Sanderson K, Walters RJ, et al. PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival. Ashktorab H, editor. PLoS One 2013;8:e65479.
14. Sarshekeh AM, Advani S, Overman MJ, Manyam G, Kee BK, Fogelman DR, et al. Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer. PLoS One 2017;12:e0173345.
15. Marshall J, Lenz H, Xiu J, Wafik E, Swensen J, El Ghazaly H, et al. Molecular variances between rectal and left-sided colon cancers. J Clin Oncol 2017;35:suppl 4S; abstract 522.
16. Bettington M, Walker N, Clouston A, Brown I, Leggett B, Whitehall V. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology 2013;62:367–86.
17. Lan Y-T, Jen-Kou L, Lin C-H, Yang S-H, Lin C-C, Wang H-S, et al. Mutations in the RAS and PI3K pathways are associated with metastatic location in colorectal cancers. J Surg Oncol 2015;111:905–10.